Standout Papers

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the I... 2013 2026 2017 2021 2.5k
  1. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (2015)
    Peter G. Pappas, Carol A. Kauffman et al. Clinical Infectious Diseases
  2. Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America (2016)
    Peter G. Pappas, Carol A. Kauffman et al. Clinical Infectious Diseases
  3. Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care (2013)
    Cornelius J. Clancy, M. Hong Nguyen Clinical Infectious Diseases
  4. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections (2016)
    Ryan K. Shields, Liang Chen et al. Antimicrobial Agents and Chemotherapy
  5. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections (2023)
    Pranita D. Tamma, Samuel L Aitken et al. Clinical Infectious Diseases
  6. Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia (2017)
    Ryan K. Shields, M. Hong Nguyen et al. Antimicrobial Agents and Chemotherapy
  7. Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-ResistantAcinetobacter baumannii, andStenotrophomonas maltophiliaInfections (2021)
    Pranita D. Tamma, Samuel L Aitken et al. Clinical Infectious Diseases
  8. Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), andPseudomonas aeruginosawith Difficult-to-Treat Resistance (DTR-P. aeruginosa) (2021)
    Pranita D. Tamma, Samuel L Aitken et al. Clinical Infectious Diseases
  9. Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa) (2020)
    Pranita D. Tamma, Samuel L Aitken et al. Clinical Infectious Diseases
  10. Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa) (2022)
    Pranita D. Tamma, Samuel L Aitken et al. Clinical Infectious Diseases

Immediate Impact

17 from Science/Nature 137 standout
Sub-graph 1 of 15

Citing Papers

Multidrug-resistant Gram-negative bacterial infections
2025 Standout
A broad-spectrum lasso peptide antibiotic targeting the bacterial ribosome
2025 StandoutNature
114 intermediate papers

Works of Cornelius J. Clancy being referenced

In Vitro Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-Tazobactam
2021
Carbapenem-Resistant Klebsiella pneumoniae Strains Exhibit Diversity in Aminoglycoside-Modifying Enzymes, Which Exert Differing Effects on Plazomicin and Other Agents
2014
and 58 more

Author Peers

Author Last Decade Papers Cites
Cornelius J. Clancy 9044 8720 4998 254 16.5k
Johan W. Mouton 5917 7818 5307 348 17.9k
Matteo Bassetti 6452 7019 6735 560 18.6k
Brad Spellberg 9324 6945 5189 214 20.9k
John Turnidge 6124 5606 6929 259 16.7k
Mariana Castanheira 7857 7609 8780 411 17.8k
Keith S. Kaye 4370 5501 8365 409 19.4k
Victor L. Yu 5451 8383 2262 192 16.1k
George G. Zhanel 3717 7199 7750 441 17.9k
Peter C. Appelbaum 5370 7595 4110 371 15.3k
Mical Paul 3305 6161 3679 317 15.7k

All Works

Loading papers...

Rankless by CCL
2026